Focus:
Deals Analysis
-
26 March 2019
North America’s pharma industry sees a rise of 1% in deal activity in Q4 2018
North America's pharma industry saw a rise of 1% in overall deal activity during Q4 2018, when compared to the last four-quarter average, according to GlobalData's deals database. Embed this...
-
26 March 2019
Europe’s pharma industry sees a drop of 3.9% in deal activity in February 2019
Europe's pharma industry saw a drop of 3.9% in deal activity during February 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart Embed...
-
26 March 2019
North America’s pharma industry sees a drop of 15.7% in deal activity in February 2019
North America's pharma industry saw a drop of 15.7% in deal activity during February 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this chart...
-
21 March 2019
US pharma industry sees a drop of 16.7% in deal activity in February 2019
The US pharma industry saw a drop of 16.7% in overall deal activity during February 2019, when compared with the last 12-month average, according to GlobalData's deals database. Embed this...
-
21 March 2019
UK pharma industry sees a drop of 25% in deal activity in Q4 2018
The UK pharma industry saw a drop of 25% in overall deal activity during Q4 2018, when compared with the last four-quarter average, according to GlobalData's deals database. Embed this...
-
21 March 2019
China’s pharma industry sees a rise of 16.7% in deal activity in Q4 2018
China's pharma industry saw a rise of 16.7% in overall deal activity during Q4 2018, when compared with the last four-quarter average, according to GlobalData's deals database. Embed this chart...
-
18 March 2019
Pharma industry venture financing deals in February 2019 total $1.7bn globally
Total pharma industry venture financing deals in February 2019 worth $1.7bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and...
-
18 March 2019
Pharma industry M&A deals in February 2019 total $28.83bn globally
Total pharma industry M&A deals in February 2019 worth $28.83bn were announced globally, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste...
-
15 March 2019
Pharma deal activity for Q4 2018 reaches $21.11bn
Total pharma deals worth $21.11bn were announced during Q4 2018, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste the code below...
-
14 March 2019
Pharma industry M&A deals in Q4 2018 total $11.95bn in United States
Total US pharma industry M&A deals in Q4 2018 worth $11.95bn were announced, according to GlobalData's deals database. Embed this chart Embed this chart into your website Copy and paste...